CPIX
NASDAQ · Pharmaceuticals
Cumberland Pharmaceuticals
$5.95
+0.38 (+6.82%)
Open$5.56
Previous Close$5.57
Day High$5.96
Day Low$5.50
52W High$6.61
52W Low$1.85
Volume—
Avg Volume42.7K
Market Cap85.70M
P/E Ratio—
EPS$-0.49
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+495.8% upside
Current
$5.95
$5.95
Target
$35.45
$35.45
$27.92
$35.45 avg
$53.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 46.70M | 45.81M | 7.91M |
| Net Income | -2,974,686 | -2,626,010 | 1.22M |
| Profit Margin | -6.4% | -6.1% | 15.4% |
| EBITDA | 1.42M | 1.32M | 2.16M |
| Free Cash Flow | — | — | 556.1K |
| Rev Growth | +2.0% | +2.0% | +3.2% |
| Debt/Equity | 0.21 | 0.21 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |